Risk screening for spontaneous preterm labour

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 21, Issue 5, 2007, Pages 821-830

  Khan, Khalid S ^b   Honest, Honest ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b NONE

Author keywords

randomised controlled trials; screening; systematic review; therapeutic effectiveness

Indexed keywords

ANTIBIOTIC AGENT; FISH OIL; PROGESTERONE;

AMNIOCENTESIS; ANAMNESIS; CLINICAL DECISION MAKING; CONCEPTUAL FRAMEWORK; GESTATIONAL AGE; HUMAN; NEWBORN MORBIDITY; NON INVASIVE MEASUREMENT; PERINATAL MORBIDITY; PERINATAL MORTALITY; PREGNANT WOMAN; PREMATURE LABOR; PREMATURITY; PRIMARY PREVENTION; PRIORITY JOURNAL; PROBABILITY; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION; SCREENING TEST; SMOKING CESSATION; SPONTANEOUS ABORTION; TREATMENT RESPONSE; VAGINITIS;

FEMALE; HUMANS; MASS SCREENING; OBSTETRIC LABOR, PREMATURE; PATIENT SELECTION; PREGNANCY; PRENATAL CARE; RISK FACTORS; TREATMENT OUTCOME;

EID: 35148886082     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2007.03.004     Document Type: Review

References (40)

1. Khan K.S., Honest H., and Bachmann L.M. A generic framework for making clinical decisions integrating diagnostic and therapeutic research evidence in preterm birth. Fetal Maternal Med Rev 14 (2003) 239-249
2. The UK National Screening Committee. Criteria for appraising the viability, effectiveness and appropriateness of a screening programme (2006). http://www.nsc.nhs.uk/pdfs/criteria.pdf (last visited October 2006)
3. Wildschut H.I.J., Weiner C.P., and Peters T.J. When to Screen in Obstetrics and Gynecology. 2nd edn. (2006), Saunders Elsevier, Philadelphia
4. Seubert D.E., Stetzer B.P., Wolfe H.M., et al. Delivery of the marginally preterm infant: what are the minor morbidities?. Am J Obstet Gynecol 181 (1999) 1087-1091
5. Maternal and Child Health Consortium. 6th Annual Report: Confidential Enquiries into Stillbirths and Deaths in Infancy (CESDI), 1999.
6. Peters K.D., Kochanek K.D., and Murphy S.L. Deaths: final data for 1996. Natl Vital Stat Rep 47 (1998) 1-100
7. Paneth N.S. The problem of low birth weight. Future Child 5 (1995) 19-34
8. Stewart A.L., Rifkin L., Amess P.N., et al. Brain structure and neurocognitive and behavioural function in adolescents who were born very preterm. Lancet 353 (1999) 1653-1657
9. Wolke D., and Meyer R. Cognitive status, language attainment, and prereading skills of 6-year- old very preterm children and their peers: the Bavarian Longitudinal Study. Dev Med Child Neurol 41 (1999) 94-109
10. Honest H., Bachmann L.M., Coomarasamy A., et al. Accuracy of cervical transvaginal sonography in predicting preterm birth. Ultrasound Obstet Gynecol 22 (2003) 305-322
11. Honest H., Bachmann L.M., Gupta J.K., et al. Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review. BMJ 325 (2002) 301
12. Honest H., and Khan K.S. Preterm labour: prediction and treatment. In: Bonner J., and Dunlop W. (Eds). Recent Advances in Obstetrics and Gynaecology 23 (2005), RSM Press, London 15-26
13. Coomarasamy A., Thangaratinam S., Gee H., et al. Progesterone for the prevention of preterm birth: A critical evaluation of evidence. Eur J Obstet Gynecol Reprod Biol 129 (2006) 111-118
14. Smith G.D., and Egger M. Who benefits from medical interventions?. BMJ 308 (1994) 72-74
15. Glasziou P.P., and Irwig L.M. An evidence based approach to individualising treatment. BMJ 311 (1995) 1356-1359
16. Guyatt G.H., Sackett D.L., Sinclair J.C., et al. Users' guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group. JAMA 274 (1995) 1800-1804
17. Khan K.S., and Chien P.F. Seizure prophylaxis in hypertensive pregnancies: a framework for making clinical decisions. Br J Obstet Gynaecol 104 (1997) 1173-1179
18. Sinclair J.C., Cook R.J., Guyatt G.H., et al. When should an effective treatment be used? Derivation of the threshold number needed to treat and the minimum event rate for treatment. J Clin Epidemiol 54 (2001) 253-262
19. Kunz R., Neumayer H.H., and Khan K.S. When small degrees of bias in randomized trials can mislead clinical decisions: an example of individualizing preventive treatment of upper gastrointestinal bleeding. Crit Care Med 30 (2002) 1503-1507
20. Cook R.J., and Sackett D.L. The number needed to treat: a clinically useful measure of treatment effect. BMJ 310 (1995) 452-454
21. Kristiansen I.S., Gyrd-Hansen D., Nexoe J., et al. Number needed to treat: easily understood and intuitively meaningful? Theoretical considerations and a randomized trial. J Clin Epidemiol 55 (2002) 888-892
22. Laupacis A., Sackett D.L., and Roberts R.S. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 318 (1988) 1728-1733
23. Khan K.S., Bachmann L.M., and ter Riet G. Systematic reviews with individual patient data meta-analysis to evaluate diagnostic tests. Eur J Obstet Gynecol Reprod Biol 108 (2003) 121-125
24. Khan K.S., Kunz R., Kleijnen J., et al. Systematic Reviews to Support Evidence-based Medicine: How to Review and Apply Findings of Systematic Reviews (2003), Royal Society of Medicine, London
25. Khan K.S., Kunz R., Kleijnen J., et al. Five steps to conducting a systematic review. J R Soc Med 96 (2003) 118-121
26. Cochrane Methods Group on Systematic Review of Screening and Diagnostic Tests: Recommended Methods, last updated on 9 February 1998. Available at http://www.cochrane.org/cochrane/sadtdoc1.htm.
27. Deeks J.J. Systematic reviews of evaluation of diagnostic and screening tests. In: Egger M., Davey Smith G., and Altman D.G. (Eds). Systematic Reviews in Health Care Meta-analysis in Context (2001), BMJ Publishing Group, 2 edn 248-282
28. Deville W.L., Buntinx F., Bouter L.M., et al. Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol 2 (2002) 9
29. Honest H., and Khan K.S. Systematic reviews of test accuracy studies in reproductive health. WHO Reproductive Health Library (No 5) (2002), WHO/RHR, Geneva
30. Khan K.S., ter Riet G., Popay J., et al. Study quality assessment (phase 5): Conducting the review (stage II). CRD report no. 4. Undertaking systematic reviews of research on effectiveness (2001) 1-20. http://www.york.ac.uk/inst/crd/report4.htm Last updated 2001 Available at
31. Khan K.S., Dinnes J., and Kleijnen J. Systematic reviews to evaluate diagnostic tests. Eur J Obstet Gynecol Reprod Biol 95 (2001) 6-11
32. de Carvalho M.H.B., Bittar R.E., Brzt M.D., et al. Prediction of preterm delivery in the second trimester. Obstet Gynecol 105 (2005) 532-536
33. da Fonseca E.B., Bittar R.E., Carvalho M.H.B., et al. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: A randomized placebo-controlled double-blind study. Am J Obstet Gynecol 188 (2003) 419-424
34. Ioannidis J.P., and Lau J. Heterogeneity of the baseline risk within patient populations of clinical trials: a proposed evaluation algorithm. Am J Epidemiol 148 (1998) 1117-1126
35. Schmid C.H., Lau J., McIntosh M.W., et al. An empirical study of the effect of the control rate as a predictor of treatment efficacy in meta-analysis of clinical trials. Stat Med 17 (1998) 1923-1942
36. Furukawa T.A., Guyatt G.H., and Griffith L.E. Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses. Int J Epidemiol 31 (2002) 72-76
37. Cates C.J. Simpson's paradox and calculation of number needed to treat from meta-analysis. BMC Med Res Methodol 2 (2002) 1
38. Guyatt G.H., Tugwell P.X., Feeny D.H., et al. A framework for clinical evaluation of diagnostic technologies. CMAJ 134 (1986) 587-594
39. Sackett D.L., and Holland W.W. Controversy in detection of disease. Lancet 2 (1975) 357-359
40. Drummond M., O'Brien B., Stoddard G., et al. Methods for the Economic Evaluation of Health Care Programmes. 2nd edn (1997), Oxford University Press, Oxford